NASDAQ | ETF
The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market.
Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 7.24% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 7.12% |
| NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 5.56% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.36% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 4.94% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 4.80% |
| 0QIU | Novo Nordisk A/S Class B | 3.84% | ||
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 3.39% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.36% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 2.99% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 2.89% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 2.43% |
| ARGX | Argen-X | Healthcare | Biotechnology | 2.40% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 2.39% |
| CVS | CVS Health Corp | Healthcare | Healthcare Plans | 2.29% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.14% |
| MCK | McKesson Corporation | Healthcare | Medical Distribution | 2.07% |
| LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 2.07% |
| EL | EssilorLuxottica S. A. | Healthcare | Medical Instruments & Supplies | 1.91% |
| UCB | UCB SA | Healthcare | Biotechnology | 1.91% |